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Abstract
Background: Malignant mixed mullerian tumors (MMMT) are rare biphasic malignant neoplasm.
The commonest site of their occurrence in female genital tract is body of the uterus. MMMT of the
cervix is extremely rare.
Case presentation: We report the clinical, pathological and immunohistochemical profile and
diagnostic difficulties in a case of giant MMMT of the cervix in a postmenopausal woman who
presented with a large cervical mass. On microscopic examination, initially tumor appeared to be
endometrial stromal sarcoma, however, immunohistochemical examination revealed the biphasic
nature of the tumor. The malignant epithelial component was basaloid squamous carcinoma with
homologous sarcomatous component. The patient was treated with surgery. However, she
experienced vaginal vault recurrence four months after the initial treatment, which was successfully
treated with pelvic radiotherapy.
Conclusion: Accurate diagnosis of cervical MMMT is important for appropriate treatment of the
patient.
Background
Malignant mixed mullerian tumors (MMMT) are rare
biphasic malignant neoplasm. The commonest site of
occurrence of female genital tract MMMT is the uterine
corpus. MMMT of the cervix is extremely rare. It was first
described by Ferriera in 1951 [1]. Approximately 50 cases
have been reported in the English language literature on
this rare entity [2].
We report the clinical, pathological and immunohisto-
chemical profile and diagnostic difficulties in a case of
giant MMMT of the cervix where malignant epithelial
component resembled endometrial stromal sarcoma.
Case presentation
A 60-year-old postmenopausal woman presented with
lump in lower abdomen of 2 months duration. Abdomi-
nal examination revealed a large, irregular, firm supra-
pubic mass. On pelvic examination, the same mass was
felt in the vagina. Cervix and uterus were not felt sepa-
rately from the mass. Computed tomography (CT) scan
showed a large, well defined heterogeneous abdomino-
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pelvic mass. Serum CA-125 level was 52.3 U/mL. Explor-
atory laparotomy was performed, which revealed a large,
bosselated mass arising from the cervix. Body of the
uterus, bilateral ovaries, tubes and other abdomino-pelvic
organs were within normal limits. Total abdominal hys-
terectomy with bilateral salpingo-oophorectomy with
complete excision of the mass was done after identifying
the ureters from pelvic brim to their entry into the urinary
bladder. Her postoperative recovery was uneventful.
The patient was kept under close observation after initial
treatment. Four months after surgery, on routine follow-
up, vaginal cytology showed the malignant squamous
component of MMMT. The recurrence was confirmed by
colposcopy-guided biopsy from the vaginal vault. Physi-
cal examination and CT-scan did not reveal any evidence
of disease elsewhere. This recurrence was treated with rad-
ical pelvic radiotherapy (RT) (external pelvic RT 60 Gy in
30 fractions plus 2 intracavitary applications of 6 Gy
each). The patient is free of disease at eighteen months
after the treatment of recurrence.
Pathologic findings
Gross examination of the surgical specimen revealed a 28
× 20 × 15 cm bosselated, mass arising from the cervix. The
cervical canal was distorted because of the mass. On cut
surface, the mass was fleshy, solid with cystic areas.
On hematomylin and eosin staining, the entire tumor
showed cellular whorls dispersed amidst pale sarcoma-
tous stroma. The cells in whorls were round to short spin-
dle shaped and had moderate mitotic activity (figure 1).
Although no vessels were seen in the center of these
whorls, the whorled appearance was reminiscent of an
endometrial stromal sarcoma. Hence, the preliminary
diagnosis of endometrial stromal sarcoma (ESS) was
made. Additional sections however revealed that whorled
areas had basaloid squamous carcinoma in the center (fig-
ure 1 inset). A panel of immunohistochemical tests was
performed and whorled basaloid areas were positive for
cytokeratin (figure 2), epithelial membrane antigen and
CD 10 but were negative for vimentin confirming their
epithelial nature. The stromal component of the tumor
was highlighted on vimentin stain (figure 3). The stromal
element was sarcomatous and showed diffuse vimentin
and focal SMA positivity. SMA, S-100, calponin, inhibin,
Mic-2, desmin and myoglobin were negative in the
basaloid islands. No heterologous elements were seen.
The final diagnosis was homologous malignant mixed
mullerian tumor with basaloid squamous carcinoma.
Discussion
Cervical MMMT usually occur in post-menopausal
women with mean age at diagnosis of 61 to 69 years
although the age range in the literature varies from 12 to
93 years [3-6]. The commonest clinical features are vagi-
nal bleeding, abnormal vaginal cytology and polypoidal
cervical mass [3-6]. However, the presenting feature in our
case was a large abdomino-pelvic mass.
MMMT are biphasic tumors that consist of an admixture
of malignant epithelial and mesenchymal components.
The epithelial component represents a variety of different
histological sub-types, alone or in combination, which
include squamous cell carcinoma, basaloid squamous
carcinoma, adenocarcinoma, adeno-squamous carci-
noma, adenoid-basal carcinoma, adenoid-cystic carci-
noma and undifferentiated carcinoma [3-5]. The
On immunohistochemistry the whorled areas were cytoker- atin positive while the surrounding sarcomatous element was  negative (ABC ×100) Figure 2
On immunohistochemistry the whorled areas were cytoker-
atin positive while the surrounding sarcomatous element was 
negative (ABC ×100).
Photomicrograph showing a basaloid tumor with small cells  arranged in whorled manner (H&E ×200) Figure 1
Photomicrograph showing a basaloid tumor with small cells 
arranged in whorled manner (H&E ×200). Inset: Squamous 
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sarcomatous component may be homologous (fibrob-
lasts and smooth muscle) or heterologous (cartilage, stri-
ated muscle, bone etc). On immunohistochemical
examination, both epithelial and sarcomatous compo-
nents of MMMT may show positivity for broad spectrum
cytokeratins, high molecular weight cytokeratin, low
molecular weight cytokeratin and epithelial membrane
antigen. Sarcomatous components may be positive for
vimentin, desmin, muscle specific actin (MSA) and
smooth muscle-specific actin (SMA) [3].
These tumors must be differentiated from other tumors
on histopathology. Our case illustrates the varied pattern
of MMMT and its tendency to mimic ESS. The islands of
squamous differentiation were the clue to the diagnosis,
as they are not seen in ESS. Extrauterine ESS arising in the
cervix is extremely rare with only three reported cases
available in the English literature [2]. These tumors usu-
ally arise in the endocervical polyp and histologically
resemble ESS of the uterus. ESS are classically positive for
CD10 which overlaps with CD 10 positivity in some cases
of MMMT [7] as seen in our case. Other tumors that may
mimic MMMT and should be differentiated from it are
sarcomatoid carcinoma and mullerian adenosarcoma. In
sarcomatoid carcinoma, the carcinomatous component
frequently merges with the sarcomatous, as opposed to
the sharp distinction seen in MMMT. Mullerian adenosa-
rcoma is relatively easy to differentiate from MMMT, as
the epithelial component in the former is benign.
Grayson et al., [3] studied human papillomavirus (HPV)
status in eight patients with cervical MMMT. In all cases,
HPV-DNA was detected by polymerase chain reaction.
Interestingly, using in-situ hybridization technique they
demonstrated HPV-16 DNA in the nuclei of both epithe-
lial and sarcomatous components in three cases. This
observation supports a metaplastic theory of histogenesis
of these tumors.
Clement et al., [5] reported the largest single series of nine
cases of cervical MMMT. They suggested that compared to
its uterine counterpart, cervical MMMT is more often con-
fined to the uterus at presentation, frequently has non-
glandular epithelial component and may have better
prognosis. Due to rarity of this tumor, no evidence based
management guidelines are available. Surgery is the prin-
cipal modality of treatment. Although adjuvant chemo-
therapy and/or radiotherapy have been used, their role is
not well-defined. Radical radiotherapy with or without
chemotherapy is recommended for locally advanced dis-
ease. Patients with metastatic disease are treated with pal-
liative chemotherapy. Commonly used chemotherapeutic
agents are cisplatin, doxorubicin, ifosphamide or cyclo-
phosphamide. The clinical behavior of these tumors is
dominated by the carcinomatous component [8]. In our
case, only the epithelial squamous component was seen at
recurrence, which was successfully treated by radiotherapy
that is also the treatment of choice for cervical squamous
cell carcinoma.
Conclusion
Cervical malignant mixed mullerian tumors are rare
malignancies that may at times present diagnostic difficul-
ties to the clinician. They are best treated by surgery with
or without adjuvant radiation and/or chemotherapy.
Accurate diagnosis is essential for appropriate treatment
and prognosticating the disease.
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